Abstract:Objective To investigate the effect of directional soft-channel intracranial hematoma drainage combined with autologous serum in the treatment of hypertensive cerebral hemorrhage.Methods From January 2018 to June 2019,70 patientswith hypertensive cerebral hemorrhage treated in our hospitalwere selected as the research subjects.They were divided into control group (n=35)and observation group (n=35)according to the random number table method.In the control group,directional soft-channel intracranial hematoma drainage combined with Urokinase was used,and in the observation group,directional soft-channel intracranial hematoma drainage combined with autologous serum was applied.The total clinical treatment efficiency,total incidence of complications,and changes in the Glasgow coma scale(GCS)and Scandinavian stroke scale(SSS)scores of patients in the two groupswere compared.Results The total effective rate of clinical treatment in the observation group was 97.14%,higher than 82.86%in the control group,and the difference was statistically significant(P<0.05).The total incidence of complications in the observation group was 5.71%,lower than 22.86%in the control group,and the difference was statistically significant(P<0.05).Before treatment,there were no significant difference in GCSor SSS scores between the two groups(P>0.05).After treatment,the GCS scores in the two groupswere higher than those before treatment,the SSS scoreswere lower than those before treatment,in the observation group,the GCS score was higher than that of the control group,the SSS score was lower than that of the control group,and the differenceswere statistically significant(P<0.05).Conclusion Patientswith hypertensive intracerebral hemorrhage treated with directional soft-channel intracranial hematoma drainage combined with autologous serum obtains remarkable effects,which can greatly improve the GCS and SSS scores of patients,and improve their coma and neurological injury with a high total effective rate and few complications.